12-O-Tiglylphorbol-13-isobutyrateCAS# 92214-54-5 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 92214-54-5 | SDF | Download SDF |
PubChem ID | 102004896 | Appearance | White powder |
Formula | C29H40O8 | M.Wt | 516.62 |
Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | CC=C(C)C(=O)OC1C(C2(C(C=C(CC3(C2C=C(C3=O)C)O)CO)C4C1(C4(C)C)OC(=O)C(C)C)O)C | ||
Standard InChIKey | MVWXLRYZCZSBKW-MYFPXGEUSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 12-O-Tetradecanoylphorbol-13-acetate has cytotoxic against in vitro P-388 lymphocytic leukemia and KB nasopharyngeal carcinoma cell. |
12-O-Tiglylphorbol-13-isobutyrate Dilution Calculator
12-O-Tiglylphorbol-13-isobutyrate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9357 mL | 9.6783 mL | 19.3566 mL | 38.7132 mL | 48.3915 mL |
5 mM | 0.3871 mL | 1.9357 mL | 3.8713 mL | 7.7426 mL | 9.6783 mL |
10 mM | 0.1936 mL | 0.9678 mL | 1.9357 mL | 3.8713 mL | 4.8391 mL |
50 mM | 0.0387 mL | 0.1936 mL | 0.3871 mL | 0.7743 mL | 0.9678 mL |
100 mM | 0.0194 mL | 0.0968 mL | 0.1936 mL | 0.3871 mL | 0.4839 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Phosphocreatine disodium salt
Catalog No.:BCC7918
CAS No.:922-32-7
- Capecitabine-2',3'-cyclic carbonate
Catalog No.:BCC8903
CAS No.:921769-65-5
- Neuromedin N (rat, mouse, porcine, canine)
Catalog No.:BCC5840
CAS No.:92169-45-4
- Cysteine Protease inhibitor
Catalog No.:BCC5301
CAS No.:921625-62-9
- Fmoc-D-Lys(Boc)-OH
Catalog No.:BCC3526
CAS No.:92122-45-7
- ent-16-Kaurene-3beta,15beta,18-triol
Catalog No.:BCN6624
CAS No.:921211-29-2
- 4'-Methoxypuerarin
Catalog No.:BCN2901
CAS No.:92117-94-7
- Schisanlactone C
Catalog No.:BCN3314
CAS No.:92051-27-9
- Schisanlactone D
Catalog No.:BCN3247
CAS No.:92051-26-8
- Tenacigenoside A
Catalog No.:BCN4458
CAS No.:920502-42-7
- P276-00
Catalog No.:BCC4415
CAS No.:920113-03-7
- Influenza Hemagglutinin (HA) Peptide
Catalog No.:BCC2563
CAS No.:92000-76-5
- SCH 529074
Catalog No.:BCC6131
CAS No.:922150-11-6
- GlcNAcstatin
Catalog No.:BCC5334
CAS No.:922163-64-2
- 5,6-Desmethylenedioxy-5-methoxyaglalactone
Catalog No.:BCN7639
CAS No.:922169-96-8
- Syringin pentaacetate
Catalog No.:BCN4459
CAS No.:92233-55-1
- Daphnilongeridine
Catalog No.:BCN4460
CAS No.:922522-15-4
- (±)-MDMA hydrochloride
Catalog No.:BCC5965
CAS No.:92279-84-0
- Sanggenon N
Catalog No.:BCN4846
CAS No.:92280-12-1
- 3-O-Methyl-3-methoxymaxterone
Catalog No.:BCC8639
CAS No.:92282-70-7
- Refametinib
Catalog No.:BCC4276
CAS No.:923032-37-5
- Refametinib R enantiomer
Catalog No.:BCC4055
CAS No.:923032-38-6
- SAR407899 hydrochloride
Catalog No.:BCC5592
CAS No.:923262-96-8
- Opicapone
Catalog No.:BCC6545
CAS No.:923287-50-7
Short-chain phorbol ester constituents of croton oil
Journal of the American Oil Chemists Society July 1984, Volume 61, Issue 7, pp 1220-1225
Five phorbol diesters, three 4-deoxy-4α-phorbol diesters, two phorbol monoesters, and one 4-deoxy-4α-phorbol monoester were isolated from a commercial sample of croton oil and characterized spectroscopically. Their purification was achieved using combinations of droplet countercurrent chromatography, low-pressure column chromatography over phase-bonded silica gel, and preparative thin layer chromatography. All of these isolates were shown to possess short-chain ester functionalities, with 12-O-Tiglylphorbol-13-isobutyrate, 12-O-(2-methyl)butyrylphorbol-13-isobutyrate, 12-O-(2-methyl)butyrylphorbol-13-acetate, 12-O-tiglyl-4-deoxy-4α-phorbol-13-isobutyrate, 12-O-tiglyl-4-deoxy-4α-phorbol-13-acetate, 12-O-(2-methyl)butyryl-4-deoxy-4α-phorbol-13-acetate, phorbol-12-tiglate and 4-deoxy-4α-phorbol-13-acetate being new compounds.